Thyroid ultrasonography, which may lead to the discovery of incidental nodules, anxiety, and high cost, is not required in evaluation for hypothyroidism.
Both over- and undertreatment of congenital hypothyroidism can result in negative behavioral outcomes.
Screening programs that measure T4 with reflex TSH in newborns with T4 below a specified cutoff have the potential to detect central congenital hypothyroidism (CCH) and have shown a higher prevalence of CCH than previously thought.
Maternal thyroid function and weight gain in early pregnancy were associated with hypothyroidism, but not hyperthyroidism.
Adult patients with obesity and hypothyroidism have lower-than-average sleep oxygen saturation.
Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.
Miscarriage risk before 20 weeks of gestation is higher among women with untreated subclinical hypothyroidism.
Researchers noted a significant increase in serum vitamin D and significant reductions in TSH following 3 months of vitamin D supplementation.
Physicians need to be aware of silent thyroiditis as a rare but serious side effect of lithium therapy.
Cognitive function was affected even in patients with subclinical hypothyroidism.
Elemental calcium — found in cow's milk — significantly limits a person's ability to absorb oral levothyroxine.
Tirosint-SOL (levothyroxine sodium oral solution) should be available within the next 6 months.
Women with subclinical hypothyroidism who undergo thyroid hormone treatment have a decreased risk of pregnancy loss, but may experience other pregnancy-related adverse outcomes.
Early detection and quick treatment with levothyroxine are essential in treating children with congenital hypothyroidism.
Half of the infants in the study had a delayed diagnosis of congenital hypothyroidism.
Women with higher-than-normal thyrotropin concentrations during pregnancy may be more likely to experience premature delivery.
Lower thyroid function was associated with a 1.24-fold higher risk for nonalcoholic fatty liver disease.
Physicians present viewpoints for and against treatment of subclinical hypothyroidism in a 60-year-old patient.
The risk was greater even for people with low-normal thyroid function.
The large study linking Agent Orange with adverse effects includes US veterans of the Korean War who also served in the Vietnam War.
Women with hyperthyroidism have increased breast cancer risk, while hypothyroidism is associated with decreased risk.
In the elderly, subclinical hypothyroidism is not associated with significantly increased risk for recurrent venous thromboembolism.
Thyroid function improved after the researchers placed the child on levothyroxine and supplemented his diet with iodized salt and a multivitamin containing iodine.
Results from the HUNT Study in Norway found an association between autoimmune diabetes and thyroid dysfunction.
Patients had reduced left middle hippocampus and right anterior hippocampus activity when judging word pairs.
No increased risk for patients with hypothyroidism treated with thyroid hormone replacement therapy.
Obese women who undergo thyroidectomy may require a higher dose of levothyroxine than nonobese women.
Thyrotropin levels within the reference range do not appear to be linked to risk for CHD events and CHD mortality.
Maternal hormone levels during pregnancy may have adverse effects on the infant's IQ later in childhood.
British study finds an association, but unable to prove cause-and-effect.
Thyroid disease, including hyperthyroidism and hypothyroidism, may be linked to fertility problems and miscarriages in women.
A number of factors contribute to the need for higher-than-expected levothyroxine dosing requirements in patients with hypothyroidism.
Higher TSH and lower FT4 thyroid hormone levels are associated with decreased risk for adverse effects in older adults.
The U.S. Preventive Services Task Force states that more evidence is needed to adequately assess the benefits or harms of thyroid screening.
An expert panel reviewing treatments for hypothyroidism has concluded that the drug levothyroxine should remain the standard of care.
An oral levothyroxine solution bested the tablet form in preventing malabsorption related to proton-pump inhibitors.
Mild hypothyroidism in women may not be linked to adverse outcomes in pregnancy.
Metformin may raise the risk for low levels of thyroid-stimulating hormone among patients with hypothyroidism.
Ischemic stroke risk does not appear to be elevated in postmenopausal women with subclinical hypothyroidism.
Gestational diabetes risk is modestly higher in pregnant women with subclinical hypothyroidism when compared with euthyroid pregnant women.
Levothyroxine absorption may be increased when administered as an oral solution, as compared with tablets, in hypothyroidism.
Women with high thyroid-stimulating hormone levels during pregnancy may have an increased risk for miscarriage.
Researchers find an independent association between subclinical hypothyroidism and diabetic nephropathy in type 2 diabetes.
Endocrinology Advisor Articles
- Trends in Cardiovascular Deaths for US Adults With and Without Diabetes
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency